Electric Remote Carrier For John Deere H Series Loaders

Feb 26, 2013

The new electric remote carrier latching system for John Deere H-Series Loaders equipped with Global or Global Category 2 Carriers provide enhanced productivity and improved operator comfort when changing loader attachments. Unlike competitive remote latching systems that require the addition of third function hydraulics and/or diverter valves for the loader, the electric remote carrier latching system uses a simple electric actuator to unlatch and latch the attachment. The activation switch is conveniently located inside of the cab so the operator no longer needs to leave the seat of the tractor in order to change attachments.

The electric remote carrier latching system is compatible with John Deere H340, H360, H380, and H480 Loaders. Compatibility with John Deere H260 (global carrier only) and H310 Loaders will be made available in the near future.

The electric remote carrier latching system is only available as a field-installed attachment, but it is included with the loader shipment.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.